Literature DB >> 22669631

Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis.

Jens-Uwe Vogel1, Jürgen Otte, Frank Koch, Hermann Gümbel, Hans Wilhelm Doerr, Jindrich Cinatl.   

Abstract

Although several host factors have been identified to influence the course of HCMV infection, it still remains unclear why in AIDS patients without highly active antiretroviral therapy human cytomegalovirus (HCMV) retinitis is one of the most common opportunistic infections, whereas in other immunosuppressed individuals it has a low incidence. It was suggested that HCMV glycoprotein B strains may be suitable as marker for virulence and HCMV retinitis. Moreover, UL144 ORF, a member of the TNF-α receptor superfamily, may play a crucial role in innate defences and adaptive immune response of HCMV infection. Furthermore, sequence analyses of HCMV genes UL128, UL130, and UL131A as major determinants of virus entry and replication in epithelial and other cell types were performed. To evaluate the association of sequence variability of depicted viral genes with HCMV retinitis and in vitro growth properties in retinal pigment epithelial cells (RPE) and human foreskin fibroblasts (HFF), we compared 14 HCMV isolates obtained from vitreous fluid and urine of AIDS patients with clinically proven HCMV retinitis. Isolates were analyzed by PCR cycle sequencing and phylogenetic analysis. In addition, sequences of HCMV strains AF1, U8, U11, VR1814, and its cell culture adapted derivates were included. Sequence analysis of gB yielded three genetic subtypes (gB type 1 (5 isolates), gB type 2 (12 isolates), and gB type 3 (5 Isolates)), whereas sequence analysis of UL144 showed a greater diversity (7 isolates type 1A, 2 isolates type 1C, 7 isolates type 2, and 3 isolates type 3). In contrast, the UL128, UL130, and UL131A genes of all low-passage isolates were highly conserved and showed no preferential clustering. Moreover, in HFF and RPE cells, all of our HCMV isolates replicated efficiently independently of their genetic subtype. In conclusion, beside a possible link between the gB subtype 2 and HCMV retinitis, our study found no direct evidence for a connection between UL144/UL128/UL130/UL131A genotypes and the incidence of HCMV retinitis in AIDS patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22669631     DOI: 10.1007/s00430-012-0244-3

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  70 in total

1.  Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients.

Authors:  N Fidouh-Houhou; X Duval; F Bissuel; V Bourbonneux; P Flandre; J L Ecobichon; M C Jordan; J L Vildé; F Brun-Vézinet; C Leport
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

2.  The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs.

Authors:  D M Forrest; E Seminari; R S Hogg; B Yip; J Raboud; L Lawson; P Phillips; M T Schechter; M V O'Shaughnessy; J S Montaner
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

3.  Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group.

Authors:  J T Holbrook; M D Davis; L D Hubbard; B K Martin; G N Holland; D A Jabs; A K Gilpin; C Meinert; D S Reshef
Journal:  Arch Ophthalmol       Date:  2000-09

4.  The human eye (retina): a site of persistent HCMV infection?

Authors:  Jens-Uwe Vogel; Corinna Fleckenstein; Mathias Wagner; Hermann O C Gümbel; Dirk Theegarten; Jindrich Cinatl; Hans Wilhelm Doerr
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-01-26       Impact factor: 3.117

5.  Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS.

Authors:  A d'Arminio Monforte; F Mainini; L Testa; L Vago; L Balotta; M Nebuloni; S Antinori; T Bini; M Moroni
Journal:  AIDS       Date:  1997-03-15       Impact factor: 4.177

6.  Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression.

Authors:  D R Hoover; Y Peng; A Saah; R Semba; R R Detels; C R Rinaldo; J P Phair
Journal:  Arch Ophthalmol       Date:  1996-07

7.  Decreased neutrophil adhesion to human cytomegalovirus-infected retinal pigment epithelial cells is mediated by virus-induced up-regulation of Fas ligand independent of neutrophil apoptosis.

Authors:  J Cinatl; R Blaheta; M Bittoova; M Scholz; S Margraf; J U Vogel; J Cinatl; H W Doerr
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

Review 8.  Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains.

Authors:  Sara Pignatelli; Paola Dal Monte; Giada Rossini; Maria Paola Landini
Journal:  Rev Med Virol       Date:  2004 Nov-Dec       Impact factor: 6.989

Review 9.  Endothelial cells in human cytomegalovirus infection: one host cell out of many or a crucial target for virus spread?

Authors:  Barbara Adler; Christian Sinzger
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

10.  The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism.

Authors:  Emma Poole; Christine A King; John H Sinclair; Antonio Alcami
Journal:  EMBO J       Date:  2006-08-24       Impact factor: 11.598

View more
  11 in total

Review 1.  Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.

Authors:  Bodo Plachter
Journal:  Med Microbiol Immunol       Date:  2016-08-12       Impact factor: 3.402

2.  Detection of herpesvirus EBV DNA in the lower respiratory tract of ICU patients: a marker of infection of the lower respiratory tract?

Authors:  I Friedrichs; T Bingold; O T Keppler; B Pullmann; C Reinheimer; A Berger
Journal:  Med Microbiol Immunol       Date:  2013-07-31       Impact factor: 3.402

Review 3.  Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.

Authors:  Niels A W Lemmermann; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2016-08-18       Impact factor: 3.402

4.  Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood.

Authors:  Vivian P Young; Margarette C Mariano; Carolyn C Tu; Kathryn M Allaire; Selmir Avdic; Barry Slobedman; Juliet V Spencer
Journal:  J Infect Dis       Date:  2017-03-15       Impact factor: 5.226

5.  Distribution of cytomegalovirus genotypes among ulcerative colitis patients in Okinawa, Japan.

Authors:  Saifun Nahar; Akira Hokama; Atsushi Iraha; Tetsuya Ohira; Tetsu Kinjo; Tetsuo Hirata; Takeshi Kinjo; Gretchen L Parrott; Jiro Fujita
Journal:  Intest Res       Date:  2018-01-18

6.  Human cytomegalovirus glycoprotein polymorphisms and increasing viral load in AIDS patients.

Authors:  Xiao-Jing Jiang; Jun Zhang; Yong Xiong; Gerhard Jahn; Hai-Rong Xiong; Zhan-Qiu Yang; Yuan-Yuan Liu
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240

7.  Positively Selected Sites at HCMV gB Furin Processing Region and Their Effects in Cleavage Efficiency.

Authors:  Lucas M Stangherlin; Felipe N de Paula; Marcelo Y Icimoto; Leonardo G P Ruiz; Maurício L Nogueira; Antônio S K Braz; Luiz Juliano; Maria C C da Silva
Journal:  Front Microbiol       Date:  2017-05-23       Impact factor: 5.640

8.  Distribution of the CMV glycoprotein gH/gL/gO and gH/gL/pUL128/pUL130/pUL131A complex variants and associated clinical manifestations in infants infected congenitally or postnatally.

Authors:  Edyta Paradowska; Agnieszka Jabłońska; Mirosława Studzińska; Beata Kasztelewicz; Małgorzata Wiśniewska-Ligier; Katarzyna Dzierżanowska-Fangrat; Teresa Woźniakowska-Gęsicka; Justyna Czech-Kowalska
Journal:  Sci Rep       Date:  2019-11-08       Impact factor: 4.379

Review 9.  Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity.

Authors:  Hsuan-Yuan Wang; Sarah M Valencia; Susanne P Pfeifer; Jeffrey D Jensen; Timothy F Kowalik; Sallie R Permar
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.818

10.  The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation.

Authors:  Jens-Uwe Vogel; Sophie Schmidt; Daniel Schmidt; Florian Rothweiler; Benjamin Koch; Patrick Baer; Holger Rabenau; Detlef Michel; Thomas Stamminger; Martin Michaelis; Jindrich Cinatl
Journal:  Cells       Date:  2019-12-20       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.